Adaptations During COVID-19 for Addiction Medicine Office-Based Practice-View Presentation

Video Transcription

Video Summary

In this video, Dr. Brian Hurley discusses adaptations during COVID-19 for addiction medicine office-based practice. He starts by explaining the use of telehealth and the regulations surrounding prescribing controlled substances through telehealth. He emphasizes the importance of minimizing in-person interactions and using telehealth platforms that are compatible with patients' technology. Dr. Hurley also mentions the use of various screening tools and measures in telehealth visits to assess patients' substance use disorder, withdrawal symptoms, treatment effectiveness, and mental health. He highlights the significance of addressing the overdose crisis and the increase in substance use during the pandemic, particularly related to opioids, synthetic opioids like fentanyl, and psychostimulants. Dr. Hurley expresses the need to provide addiction treatment remotely and deliver care to where patients are, while also acknowledging the importance of in-person services for certain cases. He mentions the flexibility in prescription duration and the prescribing of naloxone to patients at risk for overdose. Dr. Hurley shares insights on the treatment gap and the challenges surrounding addiction medicine practice during COVID-19. He concludes his presentation by discussing the Telehealth Portal AMNET, which offers various measures and tools to assist in remote addiction medicine care. Overall, Dr. Hurley provides valuable information on adapting addiction medicine practice during the pandemic and addressing the ongoing substance use crisis. No credits were mentioned for this video.

Keywords

COVID-19 adaptations

addiction medicine

telehealth

controlled substances

screening tools

substance use disorder

overdose crisis

opioids

addiction treatment

Telehealth Portal AMNET